Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

Go Back to All Clinical Trials

Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

Brief description of study

The purpose of this research study is to see if mirikizumab is effective in treating pouch-related disorders. Participants with an established diagnosis of chronic pouchitis or Crohn’s-like disease of the pouch will be offered the option of enrolling in an open-label trial with mirikizumab. The study aims to assess the clinical response to treatment with mirikizumab and endoscopic healing among patients with chronic inflammatory conditions of the pouch

Clinical Study Identifier: s25-00114

ClinicalTrials.gov Identifier: NCT06864403

Principal Investigator: Shannon Chang.

Other Investigators: Elie S Al Kazzi, Sophie M Balzora, Adam Faye, Simon J Hong, Ariela Holmer, Jordan E Axelrad, David P Hudesman.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies